Tech Company Inital Public Offerings
TFF Pharmaceuticals IPO
TFF Pharmaceuticals was bought by . The company's stock started trading on 10/25/2019.
Transaction Overview
Company Name
Announced On
10/25/2019
Transaction Type
IPO
Amount
$22,000,000
Proceeds Purpose
Per the firm's latest filing, it plans to use the net proceeds from the IPO as follows: approximately $10.5 million to fund TFF Vori, including approximately $1.4 million on pre-clinical development, analysis and preparation, $2.7 million on the manufacturing of cGMP batches for clinical trials and $6.4 million for Phase I and Phase II studies; approximately $14.9 million to fund TFF Tac-Lac, including approximately $2.1 million on pre-clinical development, analysis and preparation, $3.0 million on the manufacturing of cGMP batches for clinical trials and $9.8 million for Phase I and Phase IIb/IIIa studies; and the balance for other general corporate purposes, including general and administrative expenses, additional product development and working capital.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2801 Via Fortuna 425
Austin, TX 78746
USA
Austin, TX 78746
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) is a biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions. In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glenn Mattes
Chief Financial Officer
Kirk Coleman
Chief Scientific Officer
Brian Windsor
Browse more venture capital transactions:
Prev: 10/25/2019: Total Expert venture capital transaction
Next: 10/25/2019: Scala Computing venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs